journal article·2025-08Open access

Stable and Integrated Nanocellulose‐Covered Stents via In Situ Microbial Synthesis

Nannan Yang, Wei Huang, Jiawei Lin, Yu Chen, Zhuozhuo Wu, Yuyue Jiang, Yingjie Chen, Luhan Bao, Wenguo Cui, Zhongmin Wang

Advanced Functional Materials· Volume 35· Issue 34

Abstract

Abstract Membrane covering stents are gaining significant importance in the management of intracavitary diseases, particularly in cases where bare metal stents are inappropriate, such as those involving intracavitary tumors and leaks. It is becoming increasingly important to build an integrated membrane‐covered stent. In this study, a metallic stent coated with CaO 2 nanoparticles is fixed in a customized bioreactor. The aggregation of Komagataeibacter xylinus on the stent surface are driven by oxygen release from CaO 2 hydrolysis. Bacterial nanocellulose (BNC) is gradually synthesized in situ, ultimately achieving a BNC membrane covered around the stent's grid and forming an integrated BNC‐covered stent. The colonization of bacteria around the stent is confirmed using live/dead bacterial staining kits. This BNC‐covered stent maintains the bonding stability between membrane and stent after 10 000 compression cycles, demonstrating 3.5 N stress at 90% compression. After 2 weeks of implantation into the rabbit's trachea, airway patency and epithelial cell survival are 100%, with no inflammation or goblet cell metaplasia. The 3D printing modeling from clinical data shows that the BNC‐covered stent loaded with fluorescein isothiocyanate labeled paclitaxel (FITC‐PTX) can achieve precise drug delivery in the porcine trachea. The integrated BNC‐covered stent provides a promising platform for various intracavitary intervention.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Cellulose Research Studies · Electrospun Nanofibers in Biomedical Applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Interventional Radiology Luwan Branch of Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai 200001 China

Department of Ultrasound Medicine The first Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang 310058 P. R. China

Department of Radiology Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai 200001 China

Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China

Funding

National Natural Science Foundation of China · Program of Shanghai Academic Research Leader · Shanghai Municipal Health Commission

References (49)

Show source-provided references
1. 10.1016/j.engreg.2021.09.00610.1016/j.engreg.2021.09.006 ↗
2. 10.1016/j.bioactmat.2022.01.01710.1016/j.bioactmat.2022.01.017 ↗
3. 10.1016/S0140-6736(17)31927-X10.1016/S0140-6736(17)31927-X ↗
4. 10.1016/j.jtcvs.2020.03.01910.1016/j.jtcvs.2020.03.019 ↗
5. Wang J. · Research. · 2020 · 2020
6. 10.1016/j.jmst.2022.11.05710.1016/j.jmst.2022.11.057 ↗
7. 10.1002/adhm.20220027110.1002/adhm.202200271 ↗
8. 10.1016/j.net.2020.03.01610.1016/j.net.2020.03.016 ↗
9. 10.1021/acsami.3c0529710.1021/acsami.3c05297 ↗
10. 10.1016/j.biomaterials.2020.12047710.1016/j.biomaterials.2020.120477 ↗
11. 10.34133/research.030610.34133/research.0306 ↗
12. 10.1016/j.engreg.2023.05.00110.1016/j.engreg.2023.05.001 ↗
13. 10.1007/s42765-023-00310-710.1007/s42765-023-00310-7 ↗
14. 10.1016/j.msec.2021.11226810.1016/j.msec.2021.112268 ↗
15. 10.1039/C9NR10341D10.1039/C9NR10341D ↗
16. 10.1126/sciadv.abe949910.1126/sciadv.abe9499 ↗
17. 10.1002/advs.20220218110.1002/advs.202202181 ↗
18. 10.1016/j.msec.2020.11147210.1016/j.msec.2020.111472 ↗
19. 10.1016/j.engreg.2021.11.00510.1016/j.engreg.2021.11.005 ↗
20. 10.1002/SMMD.2023003410.1002/SMMD.20230034 ↗
21. 10.1007/s42765-022-00229-510.1007/s42765-022-00229-5 ↗
22. 10.1002/adhm.20230097010.1002/adhm.202300970 ↗
23. 10.1007/s42765-022-00252-610.1007/s42765-022-00252-6 ↗
24. 10.3389/fbioe.2021.67473810.3389/fbioe.2021.674738 ↗
25. 10.34133/2020/490718510.34133/2020/4907185 ↗
26. 10.1021/acssuschemeng.0c0012510.1021/acssuschemeng.0c00125 ↗
27. 10.1016/j.bioactmat.2021.07.00610.1016/j.bioactmat.2021.07.006 ↗
28. 10.3390/pharmaceutics1310159210.3390/pharmaceutics13101592 ↗
29. 10.1016/j.actbio.2019.11.02610.1016/j.actbio.2019.11.026 ↗
30. 10.1016/j.carbpol.2019.05.00810.1016/j.carbpol.2019.05.008 ↗
31. 10.1002/cplu.20230070410.1002/cplu.202300704 ↗
32. 10.1021/acs.biomac.0c0121110.1021/acs.biomac.0c01211 ↗
33. 10.1039/D3BM00650F10.1039/D3BM00650F ↗
34. 10.1039/D0BM02048F10.1039/D0BM02048F ↗
35. 10.1021/acsabm.2c0022610.1021/acsabm.2c00226 ↗
36. 10.1016/j.msec.2021.11239310.1016/j.msec.2021.112393 ↗
37. 10.1007/s10570-018-1940-y10.1007/s10570-018-1940-y ↗
38. 10.1007/s10570-019-02869-010.1007/s10570-019-02869-0 ↗
39. 10.1002/smll.20200393710.1002/smll.202003937 ↗
40. 10.1016/j.bbrc.2023.02.05810.1016/j.bbrc.2023.02.058 ↗
41. 10.1021/acsbiomaterials.3c0101410.1021/acsbiomaterials.3c01014 ↗
42. 10.1016/j.ijpharm.2022.12218910.1016/j.ijpharm.2022.122189 ↗
43. 10.1016/j.carbpol.2023.12137910.1016/j.carbpol.2023.121379 ↗
44. 10.1088/2752-5724/ac39ff10.1088/2752-5724/ac39ff ↗
45. 10.1109/TBME.2019.291055110.1109/TBME.2019.2910551 ↗
46. 10.1016/j.gie.2023.10.02310.1016/j.gie.2023.10.023 ↗
47. 10.4103/EUS-D-22-0010410.4103/EUS-D-22-00104 ↗
48. 10.1007/s13770-017-0057-y10.1007/s13770-017-0057-y ↗
49. 10.1016/j.carbpol.2022.11921810.1016/j.carbpol.2022.119218 ↗